News & Media / Press Releases

WBB Securities Acts as Co-Manager in $40 Million Follow-on Financing for Corium International, Inc.

May 31, 2017

WBB Securities acted as co-manager to a transaction for Corium International, Inc., a commercial stage developer of transdermal healthcare products.

Continue Reading

WBB Securities Acts as Financial Advisor to T2 Biosystems for $50 Million Credit Facility

January 5, 2017

WBB Securities acted as financial advisor to T2 Biosystems, Inc., a manufacturer of next generation diagnostic equipment, for a credit facility up to $50 million.

Continue Reading

WBB Securities Acts as Co-Manager for $300 Million Public Offering for Sarepta Therapeutics

September 29, 2016

WBB Securities acted as co-manager to a transaction for Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics.

Continue Reading

John Nolan Joins WBB to Head Asset Management Team

September 2, 2016

WBB Securities, a leading investment management, investment banking, and equity research firm, announced today that John Nolan has joined the firm as Managing Director of WBB Asset Management[1] where he will also serve as a Portfolio Manager of a concentrated long/short portfolio that focuses on the biotechnology, specialty pharmaceutical and medical device sectors.

Continue Reading

WBB Securities Sponsors BioCentury’s Annual NewsMakers Conference

September 1, 2016

WBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.

Continue Reading

WBB Securities Sponsors BioCentury’s 2016 Future Leaders Conference

March 1, 2016

WBB Securities is a sponsor of this year’s Future Leader’s conference.

Continue Reading

WBB Securities Acts as Co-manager for $100 Million in Public Offering for Cempra Pharmaceuticals

January 12, 2016

WBB Securities acted as co-manager to a transaction for Cempra Pharmaceuticals, a clinical-stage biopharmaceutical company focused on discovering and developing novel antibiotics.

Continue Reading

WBB Securities Sponsors BioCentury’s Annual NewsMakers Conference

September 1, 2015

WBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.

Continue Reading

WBB Securities Acts as Financial Advisor on $60 Million Loan for Navidea Biopharmaceuticals

May 11, 2015

WBB Securities acted as financial advisor to Navidea Biopharmaceuticals regarding a term loan with CRG (formerly Capital Royalty LP). Under the terms of the agreement, CRG will provide Navidea with initial funding of $50 million.

Continue Reading

WBB Securities Acts as Placement Agent for up to $25 Million in Equity Financing for Cytori Therapeutics

May 8, 2015

WBB Securities acted as placement agent to a transaction for Cytori Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and developing autologous cell therapies from adipose tissue to treat a variety of medical conditions.

Continue Reading